SBI Healthcare Opportunities Fund
Sectoral-PharmaVery HighOPEN-ENDED
- NAV as on 9 Nov 2026
- ₹538.37+2.68%1 day
- Return since launch
- 16.7%
- 52-week range
- ₹402.11 — ₹527.39
- AUM
- ₹6,067 Cr
SBI Healthcare Opportunities Fund is a Sectoral-Pharma equity fund from SBI Mutual Fund with ₹6,067 Cr under management, launched in 1999. Over three years it has returned 19.9% a year, against 21.2% for its category. The expense ratio is 1.99% and the SEBI riskometer reading is Very High.
Performance
SBI Healthcare Opportunities Fund NAV and returns
Growth of the fund against its category average over the period you pick.
Over 1Y this fund returned +24.8% against +19.9% for its category.
Performance
Returns
How the fund has done against its category and its benchmark.
| Period | Fund | vs category | Category | Benchmark |
|---|---|---|---|---|
| 1Y | 35.0% | +14.2 pts | 20.8% | 29.1% |
| 2Y | 21.3% | +2.2 pts | 19.1% | 17.6% |
| 3Y | 19.9% | −1.4 pts | 21.2% | 16.0% |
| 5Y | 22.6% | +7.2 pts | 15.4% | 18.5% |
| 7Y | 21.8% | +2.9 pts | 18.9% | 18.0% |
| 10Y | 19.8% | +5.4 pts | 14.4% | 17.2% |
| Period | Fund | vs category | Category | Benchmark |
|---|---|---|---|---|
| 1M | 8.9% | +0.5 pts | 8.4% | 8.5% |
| 3M | 3.1% | −0.6 pts | 3.7% | 3.7% |
| 6M | 16.6% | +2.6 pts | 14.0% | 13.6% |
| 1Y | 24.7% | +3.9 pts | 20.8% | 19.4% |
| 2Y | 13.2% | +2.4 pts | 10.8% | 9.5% |
| 3Y | 23.9% | +2.7 pts | 21.2% | 20.0% |
| 5Y | 19.1% | +3.6 pts | 15.4% | 14.6% |
| 7Y | 24.7% | +2.3 pts | 22.4% | 21.2% |
| 10Y | 14.4% | 0.0 pts | 14.4% | 13.2% |
Since launch (4 Jun 1999): 16.7%
Calendar-year returns
Category average65.8%
20.1%
-6.0%
38.2%
42.2%
-3.5%
Show as a table
| Period | Fund | vs category | Category |
|---|---|---|---|
| 2025 | -3.5% | −1.5 pts | -2.0% |
| 2024 | 42.2% | +1.4 pts | 40.9% |
| 2023 | 38.2% | +2.0 pts | 36.2% |
| 2022 | -6.0% | +2.3 pts | -8.3% |
| 2021 | 20.1% | −1.5 pts | 21.7% |
| 2020 | 65.8% | −3.0 pts | 68.8% |
Returns over one year are annualised. Shorter periods are absolute.
Costs & terms
Costs and terms
What the fund charges each year, and the rules around putting money in and taking it out.
Costs
1.98%
Expense ratio as on 5 Nov 2026
Charged yearly and already deducted from the NAV.
- Base expense
- 1.56%
- Brokerage
- 0.04%
- Transaction charges
- 0.00%
- Statutory levies
- 0.38%
- Exit load
- Exit load of 0.50% if redeemed within 15 days
- Lock-in
- None
Terms
- Min SIP
- ₹3,000
- Min lumpsum
- ₹5,000
- Plan
- GROWTH
- Fund type
- OPEN-ENDED
- Benchmark
- BSE Healthcare TRI
- Short-term capital gains
- Returns taxed at 20% if you redeem before 1 year
- Long-term capital gains
- After 1 year, returns above ₹1.25 lakh in a financial year are taxed at 12.5%
Risk
Risk
What the riskometer means for this fund, and how its ratios sit against the category.
Very High
Your principal is treated as being at very high risk — typically small cap, sectoral and thematic equity schemes.
| Ratio | Fund | Category avg | Read as |
|---|---|---|---|
| Alpha | 2.28 | 1.29 | Return earned above what the benchmark alone would have given. Higher is better. |
| Beta | 0.86 | 0.95 | How hard the fund moves when the market moves. Under 1 is steadier than the market. |
| Sharpe | 1.16 | 1.08 | Return earned for each unit of total risk taken. Higher is better. |
| Sortino | 1.95 | 1.78 | Return earned for each unit of downside risk. Higher is better. |
| Std. deviation | 14.37 | 15.93 | How widely monthly returns have varied around their own average. Lower is steadier. |
| Average of 4 category peers | |||
Portfolio
SBI Healthcare Opportunities Fund portfolio
Portfolio as of 30 Sep 2026
Asset allocation
- Equity95.5%
- Debt0.1%
- Other4.4%
Market cap split
- Large33.8%
- Mid26.9%
- Small39.3%
- P/E
- 56.69
- P/B
- 6.53
Top holdings
| Holding | Sector | Weight | Value | 3M chg | 6M chg | 1Y chg |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | 11.14% | ₹654 Cr | +11.18% | +12.11% | +10.94% |
| Divi's Laboratories Ltd. | Healthcare | 7.91% | ₹465 Cr | +5.92% | +6.59% | +6.36% |
| Acutaas Chemicals Ltd. | Healthcare | 5.03% | ₹295 Cr | +6.35% | +5.67% | +3.02% |
| Apollo Hospitals Enterprise Ltd. | Healthcare | 4.45% | ₹261 Cr | +5.21% | +5.48% | — |
| Torrent Pharmaceuticals Ltd. | Healthcare | 4.42% | ₹259 Cr | +3.33% | +3.74% | +3.66% |
| Others | Others | 4.41% | ₹259 Cr | -0.50% | -3.18% | -0.58% |
| Cipla Ltd. | Healthcare | 4.40% | ₹258 Cr | +3.52% | — | +4.59% |
| Laurus Labs Ltd. | Healthcare | 4.05% | ₹238 Cr | +3.64% | +2.93% | +3.00% |
| Max Healthcare Institute Ltd. | Healthcare | 3.80% | ₹223 Cr | +5.08% | +4.97% | +5.67% |
| Aurobindo Pharma Ltd. | Healthcare | 3.42% | ₹201 Cr | +4.17% | +2.57% | +1.93% |
| Aster DM Quality Care Ltd. | Healthcare | 3.21% | ₹188 Cr | +3.77% | +3.96% | +3.22% |
| Gland Pharma Ltd. | Healthcare | 2.96% | ₹174 Cr | +3.00% | +2.50% | +3.54% |
| Sudeep Pharma Ltd. | Healthcare | 2.79% | ₹164 Cr | +2.31% | +1.98% | — |
| Anthem Biosciences Ltd. | Healthcare | 2.75% | ₹161 Cr | +2.84% | +3.17% | +2.32% |
| Sai Life Sciences Ltd. | Healthcare | 2.60% | ₹152 Cr | +2.47% | +2.24% | — |
| CORONA Remedies Ltd. | Healthcare | 2.43% | ₹142 Cr | — | +0.29% | — |
| Biocon Ltd. | Healthcare | 2.37% | ₹139 Cr | +3.14% | +3.33% | +2.77% |
| Fortis Healthcare Ltd. | Healthcare | 2.36% | ₹139 Cr | +2.87% | +2.93% | +3.70% |
| Concord Biotech Ltd. | Healthcare | 2.25% | ₹132 Cr | +1.84% | +1.80% | +3.02% |
| Aether Industries Ltd. | Chemicals | 2.17% | ₹127 Cr | +2.72% | +3.56% | +2.68% |
| Jupiter Life Line Hospitals Ltd. | Healthcare | 2.16% | ₹127 Cr | +2.56% | +2.84% | +3.20% |
| Poly Medicure Ltd. | Healthcare | 1.82% | ₹107 Cr | +2.16% | +1.88% | +2.97% |
| Ajanta Pharma Ltd. | Healthcare | 1.79% | ₹105 Cr | +2.05% | +2.07% | — |
| Global Health Ltd. | Healthcare | 1.74% | ₹102 Cr | +1.47% | — | — |
| Mankind Pharma Ltd. | Healthcare | 1.71% | ₹100 Cr | +2.85% | +3.16% | +3.34% |
| Healthcare Global Enterprises Ltd. | Healthcare | 1.70% | ₹99.91 Cr | — | — | — |
| Krishna Institute of Medical Sciences Ltd | Healthcare | 1.69% | ₹99.36 Cr | +2.17% | +2.45% | +3.12% |
| Cohance Lifesciences Ltd. | Healthcare | 1.66% | ₹97.68 Cr | +2.01% | +0.89% | +2.68% |
| Innova Captab Ltd. | Healthcare | 1.65% | ₹96.64 Cr | — | — | — |
| Dr. Lal Pathlabs Ltd. | Healthcare | 1.62% | ₹95.38 Cr | +0.99% | — | — |
| Nephrocare Health Services Ltd. | Healthcare | 1.12% | ₹65.98 Cr | +1.08% | +1.00% | — |
| Syngene International Ltd. | Healthcare | 1.12% | ₹65.75 Cr | — | — | — |
| Rainbow Children's Medicare Ltd. | Healthcare | 0.67% | ₹39.43 Cr | +0.85% | +0.35% | +1.27% |
| Gufic Biosciences Ltd. | Healthcare | 0.29% | ₹17.28 Cr | +0.41% | +0.54% | +0.90% |
| Abbott India Ltd. | Healthcare | 0.23% | ₹13.56 Cr | +1.22% | +1.91% | +2.98% |
| Reserve Bank of India | Financial | 0.05% | ₹2.98 Cr | +0.06% | +0.07% | +0.08% |
| Novartis India Ltd. | Healthcare | 0.04% | ₹2.34 Cr | — | — | — |
Sectors
Instruments
Recent changes
| Holding | From | To | Weight |
|---|---|---|---|
| CORONA Remedies Ltd. | 0.00% | 2.43% | +2.43% |
| Innova Captab Ltd. | 0.00% | 1.65% | +1.65% |
| Sun Pharmaceutical Industries Ltd. | 12.33% | 11.14% | -1.19% |
| Others | -0.95% | -2.01% | -1.06% |
| Max Healthcare Institute Ltd. | 4.31% | 3.80% | -0.51% |
| Aurobindo Pharma Ltd. | 3.90% | 3.42% | -0.48% |
| Fortis Healthcare Ltd. | 2.82% | 2.36% | -0.46% |
| Apollo Hospitals Enterprise Ltd. | 4.91% | 4.45% | -0.46% |
| Healthcare Global Enterprises Ltd. | 1.27% | 1.70% | +0.43% |
| Jupiter Life Line Hospitals Ltd. | 2.55% | 2.16% | -0.39% |
| Aster DM Quality Care Ltd. | 3.52% | 3.21% | -0.31% |
| Biocon Ltd. | 2.67% | 2.37% | -0.30% |
| Torrent Pharmaceuticals Ltd. | 4.72% | 4.42% | -0.30% |
| Cipla Ltd. | 4.67% | 4.40% | -0.27% |
| Divi's Laboratories Ltd. | 8.17% | 7.91% | -0.26% |
| Global Health Ltd. | 1.91% | 1.74% | -0.17% |
| Aether Industries Ltd. | 2.33% | 2.17% | -0.16% |
| Dr. Lal Pathlabs Ltd. | 1.47% | 1.62% | +0.15% |
| Concord Biotech Ltd. | 2.40% | 2.25% | -0.15% |
| Anthem Biosciences Ltd. | 2.90% | 2.75% | -0.15% |
| Syngene International Ltd. | 1.24% | 1.12% | -0.12% |
| Abbott India Ltd. | 0.35% | 0.23% | -0.12% |
| Acutaas Chemicals Ltd. | 4.91% | 5.03% | +0.12% |
| Poly Medicure Ltd. | 1.94% | 1.82% | -0.12% |
| Laurus Labs Ltd. | 3.96% | 4.05% | +0.09% |
| Sai Life Sciences Ltd. | 2.52% | 2.60% | +0.08% |
| Ajanta Pharma Ltd. | 1.86% | 1.79% | -0.07% |
| Cohance Lifesciences Ltd. | 1.73% | 1.66% | -0.07% |
| Rainbow Children's Medicare Ltd. | 0.73% | 0.67% | -0.06% |
| Nephrocare Health Services Ltd. | 1.18% | 1.12% | -0.06% |
| Sudeep Pharma Ltd. | 2.84% | 2.79% | -0.05% |
| Novartis India Ltd. | 0.00% | 0.04% | +0.04% |
| Krishna Institute of Medical Sciences Ltd | 1.73% | 1.69% | -0.04% |
| Mankind Pharma Ltd. | 1.67% | 1.71% | +0.04% |
| Gland Pharma Ltd. | 2.99% | 2.96% | -0.03% |
| Gufic Biosciences Ltd. | 0.29% | 0.29% | 0.00% |
| Reserve Bank of India | 0.05% | 0.05% | 0.00% |
Compare
Similar funds
The rest of the category, so this fund’s numbers have something to sit against.
| Fund | AUM | Expense | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| Category average | ₹2,151 Cr | 1.86% | 36.9% | 21.1% | 21.1% |
 HDFC Pharma And Healthcare Fund | ₹3,501 Cr | 2.11% | 39.6% | 25.8% | — |
 Mirae Asset Healthcare Fund | ₹3,494 Cr | 2.01% | 37.3% | 20.2% | 21.1% |
 UTI Healthcare Fund | ₹1,430 Cr | 2.21% | 30.6% | 18.4% | 21.1% |
 ICICI Prudential Nifty Pharma Index Fund | ₹177 Cr | 1.13% | 39.9% | 19.9% | — |
About
About this fund
The scheme’s own words, its benchmark and the people running it.
Investment objective
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Fund managers
- Tanmaya DesaiMr. Desai is a B.E. (Electronics), MBA (Finance) and CFA (Level III).Prior to joining SBI Mutual Fund he has worked with D.J. Sanghvi College of Engineering and Patni Computer Systems Ltd.
Tools
Return calculator
What ₹10,000 a month in this fund would have grown to over each period, based on its past returns.
₹
| Over the past | Total investment | Would’ve become | Growth | Returns |
|---|---|---|---|---|
| 6 months16.58% absolute | ₹60,000 | ₹69,948 | 16.58% | |
| 1 year24.73% annualised | ₹1,20,000 | ₹1,37,354 | 14.46% | |
| 3 years23.95% annualised | ₹3,60,000 | ₹5,29,896 | 47.19% | |
| 5 years19.05% annualised | ₹6,00,000 | ₹10,06,507 | 67.75% |
Returns for 1 year and longer are annualised (CAGR); 6-month figures are absolute. Past returns are not a forecast.
How this is calculated
Each monthly instalment grows at the fund’s annualised return ÷ 12 per month until the end of the period, the same formula as our SIP calculator.
The amount compounds once a year at the fund’s CAGR for that period, the same formula as our lumpsum calculator.
Questions
Frequently asked questions
The things people ask about this scheme.
What is the NAV of SBI Healthcare Opportunities Fund?
The NAV of SBI Healthcare Opportunities Fund is ₹538.37 as on 9 Nov 2026.
What is the expense ratio of SBI Healthcare Opportunities Fund?
The expense ratio of SBI Healthcare Opportunities Fund is 1.99% per year.
What is the minimum SIP amount for SBI Healthcare Opportunities Fund?
You can start a SIP in SBI Healthcare Opportunities Fund with ₹3,000 a month.
What returns has SBI Healthcare Opportunities Fund given?
SBI Healthcare Opportunities Fund has returned 35.0% over 1 year, 19.9% over 3 years and 22.6% over 5 years (annualised).
Is there a lock-in or exit load on SBI Healthcare Opportunities Fund?
Lock-in: None. Exit load: Exit load of 0.50% if redeemed within 15 days.
How risky is SBI Healthcare Opportunities Fund?
SBI Healthcare Opportunities Fund is rated Very High on the SEBI riskometer and belongs to the Sectoral-Pharma category.
Which fund house manages SBI Healthcare Opportunities Fund?
SBI Healthcare Opportunities Fund is managed by SBI Mutual Fund, which runs 80 schemes with ₹13,34,527 Cr under management.